alexa Membranous nephropathy | Norway | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

  • Global Physicians and Healthcare Congress
    June 25-27, 2018 Dubai, UAE
  • International Conference on Medical and Health Science
    August 24-25, 2018 Tokyo, Japan
  • 11th International Conference on Clinical and Medical Case Reports
    October 22-23, 2018 Istanbul, Turkey

Relevant Topics

Membranous Nephropathy

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Membranous nephropathy

    Membranous nephropathy
     (MN) can be primary/‘idiopathic’ (IMN) or secondary. Identification and eradication of secondary causes is important in all patients. The immune system causes some damage to the kidney. In some cases of membranous nephritis there is an identifiable cause for the immune stimulation, for example lupus, hepatitis, or a tumour somewhere in the body but more often the cause is not clear.

  • Membranous nephropathy

    Disease pathophysiology:

    In membranous nephropathy extremely small complexes get stuck in the tiny parts of the kidney. The process activates or triggers your own body's immune system causing inflamation. This is what damages your kidney. The complexes and damage can only be seen on akidney biopsy where a tiny part of the kidney is examined under a very powerful microscope.


  • Membranous nephropathy

    Disease Statistics: 

    Saudi Center for Organ Transplantation, Riyadh, Kingdom of Saudi Arabia Glomerulonephritis (GN) constitutes a major cause of morbidity and mortality from renal disease. It accounts for 16-18% of patients on dialysis in the United States, 9-15% in Europe and 23.2-58.4% in the tropics. Also, various factors including genetic, racial and environmental have been incriminated in the pathogenesis of GN .


  • Membranous nephropathy

    Disease treatment: 

    Treatments include: Observation for patients with asymptomatic proteinuria Immunosuppressive therapy for progressive disease or symptomatic nephrotic syndrome - Chlorambucil, cyclosporine, tacrolimus, cyclophosphamide Corticosteroids - not effective when used alone, but used in combination with immunosuppressants Diuretics - may be used in situation of volume overload".


  • Membranous nephropathy

    Major research on disease:

    Membranous nephropathy – role of steroids. There was a male preponderance. Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. 

Expert PPTs

Speaker PPTs

  • Hayam I Gad
    Effects of Pravastatin or 12/15 lipoxygenase pathway inhibitors on indices of Diabetic nephropathy in an experimental model of diabetic renal disease
    PPT Version | PDF Version

High Impact List of Articles

Conference Proceedings